# OXYBUTYNIN CHLORIDE
> **ANDA210125** · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2018-09-06
## Drug
- **FDA Application Number:** ANDA210125
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXYBUTYNIN CHLORIDE
- **Generic name:** OXYBUTYNIN CHLORIDE
- **Active ingredients:** OXYBUTYNIN CHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TP ANDA HOLDINGS
- **Manufacturer:** TruPharma LLC
- **First approval:** 2018-09-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210125)
---
*MORVS · CC0 1.0*